Recently Diagnosed?

If you have been diagnosed with prostate cancer, you probably know your clinical information by heart - PSA level, Gleason score and clinical stage. These clinical indicators have been used for years to classify patients, like you, into one of three risk groups (low, intermediate or high). The challenge with assessing risk in this manner is that this approach is based on clinical information, which in the age of annual PSA screening, has begun to make patients look the same, despite having a more or less aggressive cancer.

Today, more than 85% of newly diagnosed patients are considered low- or intermediate-risk. These patients have similar clinical information. From a purely clinical perspective, patients can often appear the same, when in fact they can often have very different outcomes. One patient might have a slow growing cancer that will never be a problem and the second patient might have an aggressive cancer.

Your prostate cancer is not the same cancer found in your neighbor, best friend or anyone else you know who was diagnosed. You are an individual and accurately assessing the risk of your prostate cancer is vitally important as you consider the multiple treatment options available to you. Be informed: knowledge is a powerful weapon in the fight again prostate cancer. 

Click here to view an educational brochure produced by Us Too which discusses diagnostic tests available to patients including Aureon's Prostate Px test.

> Learn how Aureon’s prognostic tests can help you